Sequencing Videos Innovations
Next generation
sequencing (NGS), massively parallel or deep
sequencing area unit connected terms that describe a desoxyribonucleic acid
sequencing technology that has revolutionised genomic analysis. victimisation NGS a complete human order is sequenced inside one day. In distinction, the previous Sanger
sequencing technology, accustomed decipher the human order, needed over a decade to deliver the ultimate draft. though in order analysis NGS has principally outmoded typical Sanger sequencing, it's not however translated into routine clinical follow. There area unit variety totally different|of various} NGS platforms victimisation different
sequencing technologies, an in depth discussion of that is on the far side the scope of this text. However, all NGS platforms perform
sequencing of numerous little fragments of desoxyribonucleic acid in parallel.
Bioinformatics analyses area unit accustomed piece along these fragments by mapping the individual reads to the human reference order. every of the 3 billion bases within the human order is sequenced multiple times, providing high depth to deliver correct
information associated an insight into surprising desoxyribonucleic acid variation (figure 1). NGS is accustomed sequence entire genomes or unnatural to specific areas of interest, as well as all 22 000
cryptography genes (a whole exome) or little numbers of individual genes.
High Impact List of Articles
-
Selectively targeting TGF-β with
Trabedersen/OT-101 in treatment
of evolving and mild ards in
COVID-19
Fatih M. Uckun, Larn Hwang, Vuong Trieu
Review Article: Clinical Investigation
-
Selectively targeting TGF-β with
Trabedersen/OT-101 in treatment
of evolving and mild ards in
COVID-19
Fatih M. Uckun, Larn Hwang, Vuong Trieu
Review Article: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Placebo mechanisms for drug dose reduction: what is the evidence?
Paul Enck, Sibylle Klosterhalfen
Commentary: Clinical Investigation
-
Placebo mechanisms for drug dose reduction: what is the evidence?
Paul Enck, Sibylle Klosterhalfen
Commentary: Clinical Investigation
-
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime-time?
Mark W Hull, Julio SG Montaner
Editorial: Clinical Investigation
-
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime-time?
Mark W Hull, Julio SG Montaner
Editorial: Clinical Investigation
Relevant Topics in Clinical